rs140121121
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_005032.7(PLS3):c.321T>A(p.Gly107Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,204,373 control chromosomes in the GnomAD database, including 145 homozygotes. There are 6,296 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 4 hom., 420 hem., cov: 23)
Exomes 𝑓: 0.017 ( 141 hom. 5876 hem. )
Consequence
PLS3
NM_005032.7 synonymous
NM_005032.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.768
Genes affected
PLS3 (HGNC:9091): (plastin 3) Plastins are a family of actin-binding proteins that are conserved throughout eukaryote evolution and expressed in most tissues of higher eukaryotes. In humans, two ubiquitous plastin isoforms (L and T) have been identified. Plastin 1 (otherwise known as Fimbrin) is a third distinct plastin isoform which is specifically expressed at high levels in the small intestine. The L isoform is expressed only in hemopoietic cell lineages, while the T isoform has been found in all other normal cells of solid tissues that have replicative potential (fibroblasts, endothelial cells, epithelial cells, melanocytes, etc.). The C-terminal 570 amino acids of the T-plastin and L-plastin proteins are 83% identical. It contains a potential calcium-binding site near the N terminus. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant X-115629281-T-A is Benign according to our data. Variant chrX-115629281-T-A is described in ClinVar as [Benign]. Clinvar id is 88702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-115629281-T-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.768 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0123 (1382/111942) while in subpopulation NFE AF= 0.0184 (982/53243). AF 95% confidence interval is 0.0175. There are 4 homozygotes in gnomad4. There are 420 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0123 AC: 1381AN: 111891Hom.: 4 Cov.: 23 AF XY: 0.0123 AC XY: 419AN XY: 34059
GnomAD3 genomes
AF:
AC:
1381
AN:
111891
Hom.:
Cov.:
23
AF XY:
AC XY:
419
AN XY:
34059
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0147 AC: 2660AN: 180425Hom.: 36 AF XY: 0.0149 AC XY: 968AN XY: 64991
GnomAD3 exomes
AF:
AC:
2660
AN:
180425
Hom.:
AF XY:
AC XY:
968
AN XY:
64991
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0166 AC: 18125AN: 1092431Hom.: 141 Cov.: 27 AF XY: 0.0164 AC XY: 5876AN XY: 358179
GnomAD4 exome
AF:
AC:
18125
AN:
1092431
Hom.:
Cov.:
27
AF XY:
AC XY:
5876
AN XY:
358179
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0123 AC: 1382AN: 111942Hom.: 4 Cov.: 23 AF XY: 0.0123 AC XY: 420AN XY: 34120
GnomAD4 genome
AF:
AC:
1382
AN:
111942
Hom.:
Cov.:
23
AF XY:
AC XY:
420
AN XY:
34120
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Bone mineral density quantitative trait locus 18 Benign:1Other:1
association, no assertion criteria provided | literature only | OMIM | Oct 17, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 26, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 29, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Osteogenesis imperfecta Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 03, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at